These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6731823)

  • 1. A fluorescent spot test for coagulation factor XIII.
    Coggan M; Board PG
    Anal Biochem; 1984 Mar; 137(2):402-4. PubMed ID: 6731823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of factor XIII by SDS polyacrylamide gel electrophoresis.
    Godal HC; Gravem K; Brosstad F; Nyvold N
    Thromb Res; 1984 Sep; 35(5):577-82. PubMed ID: 6484899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific, fluorescent activity staining procedure applied to plasma and red blood cells in congenital factor XIII deficiency.
    Henriksson P; Stenberg P; Nilsson IM; Rasovic N; Kezic J; Stenbjerg S
    Br J Haematol; 1980 Jan; 44(1):141-7. PubMed ID: 6155132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reversed activity staining procedure for detection of an acquired antibody against factor XIII in a girl with factor XIII deficiency.
    Seiving B; Henriksson P; Stenberg P; Nilsson IM
    Br J Haematol; 1992 Oct; 82(2):414-6. PubMed ID: 1419823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The subunit composition of factor XIII proteins in normal and factor XIII deficient plasma and serum analysed by line immunoelectrophoresis.
    Krøll J
    Clin Chim Acta; 1989 Feb; 179(3):279-84. PubMed ID: 2714001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Factor XIII.
    Muszbek L; Katona É; Kerényi A
    Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic heterogeneity of factor XIII deficiency: first description of unstable A subunits.
    Castle S; Board PG; Anderson RA
    Br J Haematol; 1981 Jun; 48(2):337-42. PubMed ID: 7236530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Simplified radiologic factor XIII determination and its clinical use in congenital factor XIII deficiency (I)].
    Egbring R; Schmidt W; Havemann K
    Blut; 1973 Jul; 27(1):6-19. PubMed ID: 4718816
    [No Abstract]   [Full Text] [Related]  

  • 9. Factor XIII subunit B deficiency.
    Rodeghiero F; Tosetto A
    Br J Haematol; 1990 Oct; 76(2):317. PubMed ID: 2094340
    [No Abstract]   [Full Text] [Related]  

  • 10. Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen.
    Shen L; Lorand L
    J Clin Invest; 1983 May; 71(5):1336-41. PubMed ID: 6853717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proceedings: Determination of Factor XIII (fibrin-stabilizing factor) in plasma and blood platelets].
    Ballerini G; Franceschini F; Guerra S; Meduri P; Scagliarini F
    Quad Sclavo Diagn; 1973 Mar; 9(1):497-581. PubMed ID: 4210088
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the assay of the plasma factor XIII activity with dansylcadaverine incorporation method (author's transl)].
    Takahashi H; Sakuragawa N; Shibata A
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):516-24. PubMed ID: 495010
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
    Hellstern P; Schilz K; von Blohn G; Wenzel E
    Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic determination of blood coagulation Factor XIII in plasma.
    Muszbek L; Polgár J; Fésüs L
    Clin Chem; 1985 Jan; 31(1):35-40. PubMed ID: 2856900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and classification of factor XIII deficiencies.
    Kohler HP; Ichinose A; Seitz R; Ariens RA; Muszbek L;
    J Thromb Haemost; 2011 Jul; 9(7):1404-6. PubMed ID: 22946956
    [No Abstract]   [Full Text] [Related]  

  • 16. Failure to measure plasma activated factor XIII during disseminated intravascular coagulation.
    Rodeghiero F; Morbin M; Barbui T
    Ric Clin Lab; 1981; 11(4):333-6. PubMed ID: 7323610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular structure of fibrin stabilizing factors in man. II. Comparative immunologic studies on factor XIII deficient plasma and normal plasma].
    Bohn H; Becker W; Trobisch H
    Blut; 1973 May; 26(5):303-11. PubMed ID: 4122681
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of coagulation factor XIII. Critical study of the different techniques used (author's transl)].
    Soria J; Soria C; Lafay P
    Pathol Biol (Paris); 1980 May; 28(5):313-7. PubMed ID: 6770323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XIII deficiency: a genetic study of two affected kindreds in Finland.
    McDonagh J; McDonagh RP; Myllylä G; Ikkala E
    Blood; 1974 Mar; 43(3):327-32. PubMed ID: 4811819
    [No Abstract]   [Full Text] [Related]  

  • 20. Agreement between factor XIII activity and antigen assays in measurement of factor XIII: A French multicenter study of 147 human plasma samples.
    Caron C; Meley R; Le Cam Duchez V; Aillaud MF; Lavenu-Bombled C; Dutrillaux F; Flaujac C; Ryman A; Ternisien C; Lasne D; Galinat H; Pouplard C
    Int J Lab Hematol; 2017 Jun; 39(3):279-285. PubMed ID: 28318109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.